187 related articles for article (PubMed ID: 8187785)
1. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.
Troillet N; Durussel C; Bille J; Glauser MP; Chave JP
Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):911-5. PubMed ID: 8187785
[TBL] [Abstract][Full Text] [Related]
2. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A
Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
7. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
8. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
[TBL] [Abstract][Full Text] [Related]
10. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Barchiesi F; Hollis RJ; Del Poeta M; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
Clin Infect Dis; 1995 Sep; 21(3):561-4. PubMed ID: 8527544
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
12. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
[TBL] [Abstract][Full Text] [Related]
13. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Walsh TJ; Gonzalez CE; Piscitelli S; Bacher JD; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman CA
J Clin Microbiol; 2000 Jun; 38(6):2369-73. PubMed ID: 10835005
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
[TBL] [Abstract][Full Text] [Related]
15. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
Martins MD; Lozano-Chiu M; Rex JH
Clin Infect Dis; 1998 Nov; 27(5):1291-4. PubMed ID: 9827284
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Revankar SG; Dib OP; Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Redding SW; Patterson TF
Clin Infect Dis; 1998 Apr; 26(4):960-3. PubMed ID: 9564483
[TBL] [Abstract][Full Text] [Related]
18. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Lopez-Ribot JL; McAtee RK; Perea S; Kirkpatrick WR; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 1999 Jul; 43(7):1621-30. PubMed ID: 10390213
[TBL] [Abstract][Full Text] [Related]
19. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
20. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
